European Archives - Page 13 of 1121 - European Medical Journal

How Inflammation Shapes Human Ageing and Health

Researchers developed a new evolutionary framework centred on immune robustness, the ability to fight infection while limiting damage.

Cervical Cancer Study Supports De-escalating Chemotherapy

A large cohort study has found that chemoradiotherapy offers no survival advantage over radiotherapy alone in intermediate-risk cervical cancer patients—raising questions about current treatment practices.

Novel Blood Test Enhances Early Detection of HCC

This research highlights the importance of innovative blood-based diagnostics in bridging current gaps.

Guselkumab Shows Long-Term Efficacy in Ulcerative Colitis Treatment

Results from the phase 3 QUASAR trials show that guselkumab offers effective and safe induction and maintenance therapy for moderate-to-severe ulcerative colitis, with nearly 50% of patients achieving clinical remission after one year.

Metagenomics Breakthrough Saves Woman’s Eyesight After Rare Infection

A revolutionary test saved a young doctor’s eyesight by uncovering a rare infection after years of unanswered questions.

Obesity Worsens Pain and Function in Older Adults with Osteoarthritis: WCO 2025

A study from the Hertfordshire Cohort has found that older adults with obesity and radiographic knee osteoarthritis experience greater pain and impaired function compared to their non-obese peers.

Family History of Diabetes Linked to Faster CKD Progression

A large study of over 6,500 CKD patients has found that having a first-degree relative with diabetes significantly increases the risk of kidney disease progression, regardless of whether the patient has diabetes or a genetic predisposition.

Hyaluronic Acid and Laser Therapy for Rosacea

An increasingly studied adjunctive therapy is Hyaluronic Acid, known for its hydrating, regenerative, and anti-inflammatory properties.

Simultaneous Acne and Scar Treatment Proves More Effective

Beyond clinical outcomes, the simultaneous approach offered additional benefits: reduced overall treatment time and higher patient satisfaction.

New Castleman Disease Subtype Identified

A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised through the ACCELERATE natural history registry….